{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:25:01Z","timestamp":1794072301482,"version":"4.8.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,13]],"date-time":"2027-01-13T00:00:00Z","timestamp":1799798400000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX002006"],"award-info":[{"award-number":["BX002006"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK128597"],"award-info":[{"award-number":["R01DK128597"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jpet.2025.103794","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:05:25Z","timestamp":1765843525000},"page":"103794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Naringenin-functionalized polyester nanoparticles improve oral urolithin A delivery and protect against cisplatin-induced kidney injury via heme oxygenase-1 activation and mitochondrial quality control"],"prefix":"10.1016","volume":"393","author":[{"given":"Abiodun T.","family":"Wahab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghu","family":"Ganugula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sheikh-Hamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhashini","family":"Bolisetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5606-401X","authenticated-orcid":false,"given":"M.N.V. Ravi","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpet.2025.103794_bib1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12967-018-1471-1","article-title":"Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway","volume":"16","author":"Achkar","year":"2018","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.jpet.2025.103794_bib2","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41598-020-80853-6","article-title":"Combination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicity","volume":"11","author":"Arita","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jpet.2025.103794_bib3","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.1038\/s41598-019-42001-7","article-title":"The effect of locally delivered cisplatin is dependent on an intact immune function in an experimental glioma model","volume":"9","author":"Enr\u00edquez P\u00e9rez","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpet.2025.103794_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fneph.2024.1436896","article-title":"Chemotherapy-induced acute kidney injury: epidemiology, pathophysiology, and therapeutic approaches","volume":"4","author":"Lyrio","year":"2024","journal-title":"Front Nephrol"},{"issue":"2","key":"10.1016\/j.jpet.2025.103794_bib5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41418-024-01381-8","article-title":"The IDH1-R132H mutation aggravates cisplatin-induced acute kidney injury by promoting ferroptosis through disrupting NDUFA1 and FSP1 interaction","volume":"32","author":"Lai","year":"2025","journal-title":"Cell Death Differ"},{"issue":"3","key":"10.1016\/j.jpet.2025.103794_bib6","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.3390\/ijms24033028","article-title":"Role of transcription factor EB in mitochondrial dysfunction of cisplatin-induced acute kidney injury","volume":"24","author":"Wang","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.jpet.2025.103794_bib7","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41419-022-04906-6","article-title":"Mitochondrial autophagy: molecular mechanisms and implications for cardiovascular disease","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.jpet.2025.103794_bib8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41392-023-01503-7","article-title":"The mitophagy pathway and its implications in human diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"10.1016\/j.jpet.2025.103794_bib9","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41419-018-1152-2","article-title":"PINK1\/Parkin-mediated mitophagy is activated in cisplatin nephrotoxicity to protect against kidney injury","volume":"9","author":"Wang","year":"2018","journal-title":"Cell Death Dis"},{"issue":"2","key":"10.1016\/j.jpet.2025.103794_bib10","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.yexcr.2016.12.015","article-title":"PINK1\/Parkin-mediated mitophagy play a protective role in cisplatin induced renal tubular epithelial cells injury","volume":"350","author":"Zhao","year":"2017","journal-title":"Exp Cell Res"},{"issue":"11","key":"10.1016\/j.jpet.2025.103794_bib11","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011338","article-title":"Mitochondrial quality control mediated by PINK1 and parkin: links to parkinsonism","volume":"4","author":"Narendra","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.jpet.2025.103794_bib12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fphar.2012.00119","article-title":"Heme oxygenase-1, oxidation, inflammation, and atherosclerosis","volume":"3","author":"Araujo","year":"2012","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.jpet.2025.103794_bib13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3390\/biom11040589","article-title":"Heme oxygenase-1 signaling and redox homeostasis in physiopathological conditions","volume":"11","author":"Consoli","year":"2021","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.jpet.2025.103794_bib14","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41573-022-00521-4","article-title":"Targeting RNA structures with small molecules","volume":"21","author":"Childs-Disney","year":"2022","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"10.1016\/j.jpet.2025.103794_bib15","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1016\/j.apsb.2020.11.003","article-title":"Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: opportunities and emerging strategies","volume":"11","author":"Liu","year":"2021","journal-title":"Acta Pharm Sin B"},{"issue":"6","key":"10.1016\/j.jpet.2025.103794_bib16","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s42255-019-0073-4","article-title":"The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans","volume":"1","author":"Andreux","year":"2019","journal-title":"Nat Metab"},{"issue":"5","key":"10.1016\/j.jpet.2025.103794_bib17","article-title":"Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults","volume":"3","author":"Singh","year":"2022","journal-title":"Cell Rep Med"},{"issue":"13\u201314","key":"10.1016\/j.jpet.2025.103794_bib18","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.addr.2013.09.001","article-title":"Exploiting nanotechnology to overcome tumor drug resistance: challenges and opportunities","volume":"65","author":"Kirtane","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jpet.2025.103794_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1177151","article-title":"Advances in nanomaterial-based targeted drug delivery systems","volume":"11","author":"Cheng","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"issue":"2","key":"10.1016\/j.jpet.2025.103794_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"32","key":"10.1016\/j.jpet.2025.103794_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adw1358","article-title":"Dual-function polyester nanoparticles for amplified anti-inflammatory effects","volume":"11","author":"Heyns","year":"2025","journal-title":"Sci Adv"},{"issue":"39","key":"10.1016\/j.jpet.2025.103794_bib22","doi-asserted-by":"crossref","first-page":"45651","DOI":"10.1021\/acsami.3c09866","article-title":"Rationally designed naringenin-conjugated polyester nanoparticles enable folate receptor-mediated peroral delivery of insulin","volume":"15","author":"Heyns","year":"2023","journal-title":"ACS Appl Mater Interfaces"},{"issue":"21","key":"10.1016\/j.jpet.2025.103794_bib23","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.1021\/jacs.6b13231","article-title":"Next generation precision-polyesters enabling optimization of ligand-receptor stoichiometry for modular drug delivery","volume":"139","author":"Ganugula","year":"2017","journal-title":"J Am Chem Soc"},{"issue":"5","key":"10.1016\/j.jpet.2025.103794_bib24","doi-asserted-by":"crossref","first-page":"F1255","DOI":"10.1152\/ajprenal.00346.2019","article-title":"Oral delivery of nanoparticle urolithin A normalizes cellular stress and improves survival in mouse model of cisplatin-induced AKI","volume":"317","author":"Zou","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jpet.2025.103794_bib25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jconrel.2016.06.017","article-title":"DLS and zeta potential \u2013 what they are and what they are not?","volume":"235","author":"Bhattacharjee","year":"2016","journal-title":"J Control Release"},{"issue":"18","key":"10.1016\/j.jpet.2025.103794_bib26","doi-asserted-by":"crossref","first-page":"11863","DOI":"10.1021\/acsnano.4c01027","article-title":"Polyester nanoparticles with controlled topography for peroral drug delivery using insulin as a model protein","volume":"18","author":"Heyns","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jpet.2025.103794_bib27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jconrel.2021.02.009","article-title":"Nanoparticles that do not compete with endogenous ligands \u2013 molecular characterization in vitro, acute safety in canine, and interspecies pharmacokinetics modeling to humans","volume":"332","author":"Zou","year":"2021","journal-title":"J Control Release"},{"issue":"3","key":"10.1016\/j.jpet.2025.103794_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2018.07.1735","article-title":"Variation in hematologic toxicity in patients undergoing radiation therapy with concurrent weekly cisplatin for head and neck versus cervical cancer","volume":"102","author":"Sojourner","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.jpet.2025.103794_bib29","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/jrr\/rrs121","article-title":"Comparison of hematological toxicities between innovator and generic cisplatin formulations in cervical cancer patients treated with concurrent chemoradiotherapy","volume":"54","author":"Oike","year":"2013","journal-title":"J Radiat Res"},{"issue":"21","key":"10.1016\/j.jpet.2025.103794_bib30","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.1158\/1078-0432.CCR-14-1298","article-title":"Cisplatin-induced antitumor immunomodulation: a review of preclinical and clinical evidence","volume":"20","author":"de Biasi","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.jpet.2025.103794_bib31","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1158\/2326-6066.CIR-17-0235","article-title":"Cisplatin alters antitumor immunity and synergizes with PD-1\/PD-L1 inhibition in head and neck squamous cell carcinoma","volume":"5","author":"Tran","year":"2017","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"10.1016\/j.jpet.2025.103794_bib32","first-page":"451","article-title":"Cisplatin plus anti-PD-1 antibody enhanced treatment efficacy in advanced esophageal squamous cell carcinoma","volume":"12","author":"Lin","year":"2022","journal-title":"Am J Cancer Res"},{"issue":"3","key":"10.1016\/j.jpet.2025.103794_bib33","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1182\/blood-2006-02-002774","article-title":"Regulatory T cells in cancer","volume":"108","author":"Beyer","year":"2006","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jpet.2025.103794_bib34","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1158\/1078-0432.CCR-13-3141","article-title":"Molecular pathways: the immunogenic effects of platinum-based chemotherapeutics","volume":"20","author":"Hato","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.jpet.2025.103794_bib35","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/0300060514561504","article-title":"Suppressive effects of gemcitabine plus cisplatin chemotherapy on regulatory T cells in nonsmall-cell lung cancer","volume":"43","author":"Chen","year":"2015","journal-title":"J Int Med Res"},{"issue":"12","key":"10.1016\/j.jpet.2025.103794_bib36","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","article-title":"Clinical implications of T cell exhaustion for cancer immunotherapy","volume":"19","author":"Chow","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jpet.2025.103794_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.979116","article-title":"Tumor accomplice: T cell exhaustion induced by chronic inflammation","volume":"13","author":"Fang","year":"2022","journal-title":"Front Immunol"},{"issue":"20","key":"10.1016\/j.jpet.2025.103794_bib38","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1158\/0008-5472.CAN-16-0881","article-title":"Tumor eradication by cisplatin is sustained by CD80\/86-mediated costimulation of CD8+ T cells","volume":"76","author":"Beyranvand Nejad","year":"2016","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.jpet.2025.103794_bib39","doi-asserted-by":"crossref","first-page":"F385","DOI":"10.1152\/ajprenal.00335.2015","article-title":"Proximal tubule-targeted heme oxygenase-1 in cisplatin-induced acute kidney injury","volume":"310","author":"Bolisetty","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"10.1016\/j.jpet.2025.103794_bib40","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1053\/j.ajkd.2016.10.037","article-title":"Heme oxygenase 1 as a therapeutic target in acute kidney injury","volume":"69","author":"Bolisetty","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jpet.2025.103794_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fneph.2023.1156346","article-title":"The roles of heme oxygenase-1 in renal disease","volume":"3","author":"Zhai","year":"2023","journal-title":"Front Nephrol"},{"issue":"5","key":"10.1016\/j.jpet.2025.103794_bib42","doi-asserted-by":"crossref","first-page":"F726","DOI":"10.1152\/ajprenal.2000.278.5.F726","article-title":"Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis","volume":"278","author":"Shiraishi","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"10.1016\/j.jpet.2025.103794_bib43","doi-asserted-by":"crossref","first-page":"387","DOI":"10.23876\/j.krcp.20.091","article-title":"New insights into the role of heme oxygenase-1 in acute kidney injury","volume":"39","author":"Nath","year":"2020","journal-title":"Kidney Res Clin Pract"},{"issue":"W1","key":"10.1016\/j.jpet.2025.103794_bib44","doi-asserted-by":"crossref","first-page":"W498","DOI":"10.1093\/nar\/gkae406","article-title":"MolModa: accessible and secure molecular docking in a web browser","volume":"52","author":"Kochnev","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jpet.2025.103794_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.716466","article-title":"SeamDock: an interactive and collaborative online docking resource to assist small compound molecular docking","volume":"8","author":"Murail","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.jpet.2025.103794_bib46","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.freeradbiomed.2024.12.003","article-title":"Computational analysis of urolithin A as a potential compound for anti-inflammatory, antioxidant, and neurodegenerative pathways","volume":"227","author":"Massaga","year":"2025","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jpet.2025.103794_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135567","article-title":"Mechanism of interaction between urolithin A and \u03b1-glucosidase: analysis by inhibition kinetics, fluorescence spectroscopy, isothermal titration calorimetry and molecular docking","volume":"1286","author":"Yin","year":"2023","journal-title":"J Mol Str"},{"issue":"4","key":"10.1016\/j.jpet.2025.103794_bib48","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3390\/ijms22042009","article-title":"Heme oxygenase 1: a defensive mediator in kidney diseases","volume":"22","author":"Grunenwald","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.jpet.2025.103794_bib49","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3390\/pharmaceutics15020484","article-title":"Advances in oral drug delivery systems: challenges and opportunities","volume":"15","author":"Lou","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.jpet.2025.103794_bib50","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1080\/10717544.2018.1501119","article-title":"The challenges of oral drug delivery via nanocarriers","volume":"25","author":"Reinholz","year":"2018","journal-title":"Drug Deliv"},{"key":"10.1016\/j.jpet.2025.103794_bib51","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1038\/srep02534","article-title":"Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization","volume":"3","author":"Gao","year":"2013","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.jpet.2025.103794_bib52","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3390\/pharmaceutics14051113","article-title":"Functionalization of nanoparticulate drug delivery systems and its influence in cancer therapy","volume":"14","author":"Seidu","year":"2022","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.jpet.2025.103794_bib53","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1016\/j.apsb.2024.06.015","article-title":"Transepithelial transport of nanoparticles in oral drug delivery: from the perspective of surface and holistic property modulation","volume":"14","author":"Zheng","year":"2024","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"10.1016\/j.jpet.2025.103794_bib54","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41392-024-01745-z","article-title":"Nanotechnology\u2019s frontier in combatting infectious and inflammatory diseases: prevention and treatment","volume":"9","author":"Huang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.jpet.2025.103794_bib55","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J Nanobiotechnology"},{"issue":"6","key":"10.1016\/j.jpet.2025.103794_bib56","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1517\/17425247.5.6.703","article-title":"Mannose-targeted systems for the delivery of therapeutics","volume":"5","author":"Irache","year":"2008","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.jpet.2025.103794_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101767","article-title":"The PINK1\/PARK2\/optineurin pathway of mitophagy is activated for protection in septic acute kidney injury","volume":"38","author":"Wang","year":"2021","journal-title":"Redox Biol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103794_bib58","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s40478-020-01062-w","article-title":"PINK1\/PARKIN signalling in neurodegeneration and neuroinflammation","volume":"8","author":"Quinn","year":"2020","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"10.1016\/j.jpet.2025.103794_bib59","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00204-014-1239-1","article-title":"Mitochondrial dysregulation and protection in cisplatin nephrotoxicity","volume":"88","author":"Yang","year":"2014","journal-title":"Arch Toxicol"},{"issue":"10","key":"10.1016\/j.jpet.2025.103794_bib60","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41419-023-06195-z","article-title":"Pyruvate kinase M2 regulates mitochondrial homeostasis in cisplatin-induced acute kidney injury","volume":"14","author":"Xie","year":"2023","journal-title":"Cell Death Dis"},{"issue":"15","key":"10.1016\/j.jpet.2025.103794_bib61","doi-asserted-by":"crossref","first-page":"8253","DOI":"10.3390\/ijms22158253","article-title":"Heme oxygenase-1 induction by cobalt protoporphyrin ameliorates cholestatic liver disease in a xenobiotic-induced murine model","volume":"22","author":"Kim","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"14","key":"10.1016\/j.jpet.2025.103794_bib62","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1089\/ars.2019.7970","article-title":"Heme oxygenase-1 upregulation: a novel approach in the treatment of cardiovascular disease","volume":"32","author":"Bellner","year":"2020","journal-title":"Antioxid Redox Signal"},{"issue":"7","key":"10.1016\/j.jpet.2025.103794_bib63","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1172\/JCI5342","article-title":"Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury","volume":"103","author":"Otterbein","year":"1999","journal-title":"J Clin Invest"}],"updated-by":[{"DOI":"10.1016\/j.jpet.2026.104252","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000}}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525403073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525403073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:10:41Z","timestamp":1778728241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525403073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0022356525403073"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103794","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Naringenin-functionalized polyester nanoparticles improve oral urolithin A delivery and protect against cisplatin-induced kidney injury via heme oxygenase-1 activation and mitochondrial quality control","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103794","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103794"}}